Effect of intravenous N-acetylcysteine on plasma total homocysteine and inflammatory cytokines during high flux hemodialysis

Jen Pi Tsai, Fwu Lin Yang, Chih Hsien Wang, Te Chao Fang, Ru Ping Lee, Bang Gee Hsu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: Hyperhomocysteinemia and increased inflammatory cytokines are independent risk factors in patients with renal diseases. N-acetylcysteine (NAC) is an antioxidant that is known to decrease inflammatory cytokines and plasma total homocysteine (tHcy). Therefore, the aim of this study was to compare normal saline injection with and without intravenous NAC during hemodialysis (HD) in terms of changes in serum levels of tumor necrosis factor-α (TNF-α, interleukin-10 (IL-10), high-sensitivity C-reactive protein (hs-CRP) and plasma tHcy. Patients and Methods: In total, 43 high flux HD patients were enrolled at a 4-hour HD session and split into two groups, NAC (n = 22) and NS (n = 21) treatment groups, which received either a normal saline injection with intravenous NAC or without intravenous NAC, respectively. The NS group was divided into two subgroups, one with residual renal function (n = 5) and the other with anuria (n 16). The NAC group was also divided into two subgroups, one with residual renal function (n 6) and the other with anuria (n = 16). Serum TNF-α, IL-10, hs-CRP and tHcy were measured before and immediately after HD. Results: There were no significant differences in baseline characteristics, TNF-α, IL-10, hs-CRP, and tHcy levels in intra- and intergroup comparisons. Compared to pre-HD baseline values, plasma tHcy level was lower after HD in the NS group (p

Original languageEnglish
Pages (from-to)90-95
Number of pages6
JournalTzu Chi Medical Journal
Volume22
Issue number2
DOIs
Publication statusPublished - Jun 2010
Externally publishedYes

Fingerprint

Acetylcysteine
Homocysteine
Renal Dialysis
Cytokines
Interleukin-10
C-Reactive Protein
Anuria
Kidney
Hyperhomocysteinemia
Serum
Intravenous Injections
Tumor Necrosis Factor-alpha
Antioxidants
Injections

Keywords

  • High flux hemodialysis
  • Homocysteine
  • N-acetylcysteine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of intravenous N-acetylcysteine on plasma total homocysteine and inflammatory cytokines during high flux hemodialysis. / Tsai, Jen Pi; Yang, Fwu Lin; Wang, Chih Hsien; Fang, Te Chao; Lee, Ru Ping; Hsu, Bang Gee.

In: Tzu Chi Medical Journal, Vol. 22, No. 2, 06.2010, p. 90-95.

Research output: Contribution to journalArticle

Tsai, Jen Pi ; Yang, Fwu Lin ; Wang, Chih Hsien ; Fang, Te Chao ; Lee, Ru Ping ; Hsu, Bang Gee. / Effect of intravenous N-acetylcysteine on plasma total homocysteine and inflammatory cytokines during high flux hemodialysis. In: Tzu Chi Medical Journal. 2010 ; Vol. 22, No. 2. pp. 90-95.
@article{08e936fc650144e3aea4640bf46c38c7,
title = "Effect of intravenous N-acetylcysteine on plasma total homocysteine and inflammatory cytokines during high flux hemodialysis",
abstract = "Objective: Hyperhomocysteinemia and increased inflammatory cytokines are independent risk factors in patients with renal diseases. N-acetylcysteine (NAC) is an antioxidant that is known to decrease inflammatory cytokines and plasma total homocysteine (tHcy). Therefore, the aim of this study was to compare normal saline injection with and without intravenous NAC during hemodialysis (HD) in terms of changes in serum levels of tumor necrosis factor-α (TNF-α, interleukin-10 (IL-10), high-sensitivity C-reactive protein (hs-CRP) and plasma tHcy. Patients and Methods: In total, 43 high flux HD patients were enrolled at a 4-hour HD session and split into two groups, NAC (n = 22) and NS (n = 21) treatment groups, which received either a normal saline injection with intravenous NAC or without intravenous NAC, respectively. The NS group was divided into two subgroups, one with residual renal function (n = 5) and the other with anuria (n 16). The NAC group was also divided into two subgroups, one with residual renal function (n 6) and the other with anuria (n = 16). Serum TNF-α, IL-10, hs-CRP and tHcy were measured before and immediately after HD. Results: There were no significant differences in baseline characteristics, TNF-α, IL-10, hs-CRP, and tHcy levels in intra- and intergroup comparisons. Compared to pre-HD baseline values, plasma tHcy level was lower after HD in the NS group (p",
keywords = "High flux hemodialysis, Homocysteine, N-acetylcysteine",
author = "Tsai, {Jen Pi} and Yang, {Fwu Lin} and Wang, {Chih Hsien} and Fang, {Te Chao} and Lee, {Ru Ping} and Hsu, {Bang Gee}",
year = "2010",
month = "6",
doi = "10.1016/S1016-3190(10)60047-X",
language = "English",
volume = "22",
pages = "90--95",
journal = "Tzu Chi Medical Journal",
issn = "1016-3190",
publisher = "財團法人中華民國佛教慈濟慈善事業基金會",
number = "2",

}

TY - JOUR

T1 - Effect of intravenous N-acetylcysteine on plasma total homocysteine and inflammatory cytokines during high flux hemodialysis

AU - Tsai, Jen Pi

AU - Yang, Fwu Lin

AU - Wang, Chih Hsien

AU - Fang, Te Chao

AU - Lee, Ru Ping

AU - Hsu, Bang Gee

PY - 2010/6

Y1 - 2010/6

N2 - Objective: Hyperhomocysteinemia and increased inflammatory cytokines are independent risk factors in patients with renal diseases. N-acetylcysteine (NAC) is an antioxidant that is known to decrease inflammatory cytokines and plasma total homocysteine (tHcy). Therefore, the aim of this study was to compare normal saline injection with and without intravenous NAC during hemodialysis (HD) in terms of changes in serum levels of tumor necrosis factor-α (TNF-α, interleukin-10 (IL-10), high-sensitivity C-reactive protein (hs-CRP) and plasma tHcy. Patients and Methods: In total, 43 high flux HD patients were enrolled at a 4-hour HD session and split into two groups, NAC (n = 22) and NS (n = 21) treatment groups, which received either a normal saline injection with intravenous NAC or without intravenous NAC, respectively. The NS group was divided into two subgroups, one with residual renal function (n = 5) and the other with anuria (n 16). The NAC group was also divided into two subgroups, one with residual renal function (n 6) and the other with anuria (n = 16). Serum TNF-α, IL-10, hs-CRP and tHcy were measured before and immediately after HD. Results: There were no significant differences in baseline characteristics, TNF-α, IL-10, hs-CRP, and tHcy levels in intra- and intergroup comparisons. Compared to pre-HD baseline values, plasma tHcy level was lower after HD in the NS group (p

AB - Objective: Hyperhomocysteinemia and increased inflammatory cytokines are independent risk factors in patients with renal diseases. N-acetylcysteine (NAC) is an antioxidant that is known to decrease inflammatory cytokines and plasma total homocysteine (tHcy). Therefore, the aim of this study was to compare normal saline injection with and without intravenous NAC during hemodialysis (HD) in terms of changes in serum levels of tumor necrosis factor-α (TNF-α, interleukin-10 (IL-10), high-sensitivity C-reactive protein (hs-CRP) and plasma tHcy. Patients and Methods: In total, 43 high flux HD patients were enrolled at a 4-hour HD session and split into two groups, NAC (n = 22) and NS (n = 21) treatment groups, which received either a normal saline injection with intravenous NAC or without intravenous NAC, respectively. The NS group was divided into two subgroups, one with residual renal function (n = 5) and the other with anuria (n 16). The NAC group was also divided into two subgroups, one with residual renal function (n 6) and the other with anuria (n = 16). Serum TNF-α, IL-10, hs-CRP and tHcy were measured before and immediately after HD. Results: There were no significant differences in baseline characteristics, TNF-α, IL-10, hs-CRP, and tHcy levels in intra- and intergroup comparisons. Compared to pre-HD baseline values, plasma tHcy level was lower after HD in the NS group (p

KW - High flux hemodialysis

KW - Homocysteine

KW - N-acetylcysteine

UR - http://www.scopus.com/inward/record.url?scp=77955066875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955066875&partnerID=8YFLogxK

U2 - 10.1016/S1016-3190(10)60047-X

DO - 10.1016/S1016-3190(10)60047-X

M3 - Article

AN - SCOPUS:77955066875

VL - 22

SP - 90

EP - 95

JO - Tzu Chi Medical Journal

JF - Tzu Chi Medical Journal

SN - 1016-3190

IS - 2

ER -